Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Catalysts on the Horizon
OSUR Hot Sheet
Rating Summary:6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 82
Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $14.00.
Analyst, Jeffrey Frelick, said, "While still mostly a catalyst story, quarterly results were in line to slightly ahead of expectations. The Q1/12 revenue outlook of $21M appears soft due to substance abuse testing, but our bullish thesis remains intact...HCV waived sites yet to come...OSUR reported $800k of HCV sales, ahead of our $500k estimate, mostly to non-waived public health centers. OSUR continues to train its selling partners on OraQuick HCV, including physician distributors, Merck (NYSE: MRK) sales reps as well as Merck inside sales reps...We reduce 2012E sales to $100M."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $11.00 yesterday, with a 52 week range of $6.18-$11.78.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Analyst, Jeffrey Frelick, said, "While still mostly a catalyst story, quarterly results were in line to slightly ahead of expectations. The Q1/12 revenue outlook of $21M appears soft due to substance abuse testing, but our bullish thesis remains intact...HCV waived sites yet to come...OSUR reported $800k of HCV sales, ahead of our $500k estimate, mostly to non-waived public health centers. OSUR continues to train its selling partners on OraQuick HCV, including physician distributors, Merck (NYSE: MRK) sales reps as well as Merck inside sales reps...We reduce 2012E sales to $100M."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $11.00 yesterday, with a 52 week range of $6.18-$11.78.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UBS Lowers Estimates and PT on Lowe's (LOW) Messy Q1, But Bullish Case Remains
- Nomura Securities Maintains a 'Neutral' on Urban Outfitters (URBN); Staying Sidelined Despite Positive Q1 Surprises
- Auriga Maintains a 'Buy' on DSW Inc. (DSW); Guidance and Dividend Raised on Strong Q1
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
Genuity Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
